Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
about
Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1Inhibition of c-Myc activity by ribosomal protein L11Proteomic profiling of Myc-associated proteinsp53 represses c-Myc through induction of the tumor suppressor miR-145Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradationDeubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1Yin Yang gene expression ratio signature for lung cancer prognosisNeoplasia: Where We Have Been and Where We Are GoingAn ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 InteractionNeoplasia: the second decade.5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction.Signaling to p53: ribosomal proteins find their way.F-box protein specificity for g1 cyclins is dictated by subcellular localization.PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.The contribution of transactivation subdomains 1 and 2 to p53-induced gene expression is heterogeneous but not subdomain-specificThe real face of juvenile polyposis syndromeMYC is activated by USP2a-mediated modulation of microRNAs in prostate cancerCrosstalk between c-Myc and ribosome in ribosomal biogenesis and cancerFeedback regulation of c-Myc by ribosomal protein L11Ribosomal protein S14 negatively regulates c-Myc activityROS and p53: a versatile partnershipPleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53.NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression.Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine effortsTargeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.Antitumor activity of erythromycin on human neuroblastoma cell line (SH-SY5Y).Expression of androgen receptor is negatively regulated by p53.Inauhzin(c) inactivates c-Myc independently of p53.Redundancy and variation in the ubiquitin-mediated proteolytic targeting of a transcription factorβ-Catenin-dependent FGF signaling sustains cell survival in the anterior embryonic head by countering Smad4.Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases.Neoplasia: An Anniversary of Progress.Divergent effects of Wnt/β-catenin signaling modifiers on the preservation of human limbal epithelial progenitors according to culture condition.Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.Moringa oleifera Gold Nanoparticles Modulate Oncogenes, Tumor Suppressor Genes, and Caspase-9 Splice Variants in A549 Cells.Sumoylation and Its Contribution to Cancer.Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
P2860
Q24298615-CDC020B3-B09A-4E0F-B37F-A71E92FA7E79Q24315370-BC646E48-E68B-4CC3-9FFF-27A383DA425BQ24315890-0DE75E94-9C43-4D30-84E2-2D38A8B7F3F6Q24644779-83AECC9C-F8B8-4EE4-91D3-135D9F8716DAQ24673794-0C1EC6A5-8BC2-4682-8CB7-9B53B96B3248Q27003153-D9D19748-63AC-43BF-A9B7-26E8762C05A2Q28385778-1A81891A-3915-42C2-9952-3031C418A880Q28395095-C6C6C2BC-F766-4F91-ACE6-8FA6C24D9A79Q28590794-0617940E-0099-48D8-B9BE-384BBA311B75Q30484000-EB2EBFF1-5B97-4DE8-B447-97D34CA9831CQ34605000-7B9D10D0-F986-4F49-832A-F85A08507CA7Q35206381-A1F1C832-0D66-43A2-ABEF-84E14D76E608Q36119930-A5CFBE3D-2A25-4412-90FA-3266D5DD4F40Q36210911-E88D0EE8-962C-4DD1-963A-DF9E6E7DBE98Q36259624-0EA41F61-EFAC-4E8E-9635-BA48B9EEF6B3Q36381213-50849BFE-A51E-437C-8A4B-ED1DCC2BE214Q36469814-C78078CC-6604-461D-A152-6929B8348D91Q36942685-3196B4F9-146C-4713-9980-CC462EDA7A56Q37011222-EE259CB0-9BA4-4E19-ADB1-178DDEDD4828Q37048407-5A0F9DB9-5628-4FFA-BA0F-8E5A14182FA2Q37085000-A25E58CF-C12E-4282-BC08-13C305446820Q37541596-153D257B-6FF1-48F2-8565-50F6D5755C8BQ37660319-625600CD-B302-4780-ACB4-1E8BBCB70C6FQ37733990-54FF932F-AC62-4CE5-9CB0-00E1368AE421Q38059739-0C8D9290-2E76-4056-AD6F-D1D295D858DFQ39588949-2E41D7CB-3691-4043-BAC8-5D229A3F48BEQ40034771-EA4CD790-2A86-410D-82D7-A5D2353DF6E1Q42139293-C9A3B7FB-3520-4548-9E33-073A86E33B2BQ42682126-244EBE6F-A3A0-4A29-8EE2-A0D6E927AAFDQ42737506-3322316E-D425-48F1-A147-97C0992A312BQ46325214-AD98D311-F18E-444A-ADEC-8B331077DA82Q46932476-EC49B6E6-86AC-412A-A700-5ECAA64694CDQ47133043-1B58450B-78FC-4A6F-840D-9105EAC3213CQ50096089-32C85B21-9FCF-43A5-BCDC-6487EE80142DQ50428851-8C1A37A3-0B1D-4F0B-B6CA-C1A352204D1CQ51137572-5B38F7EE-6178-4EB6-BB33-F89408A02ED2Q51701495-8F2B5DDE-4F87-429F-B325-D59F302E885CQ52652467-BBEE668A-106D-458C-975D-1CA7EC0B15CF
P2860
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
@ast
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
@en
type
label
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
@ast
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
@en
prefLabel
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
@ast
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
@en
P2093
P2860
P356
P1433
P1476
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc
@en
P2093
Jayme R Gallegos
Mu-Shui Dai
P2860
P304
P356
10.1593/NEO.06334
P577
2006-08-01T00:00:00Z